Interleukin-4 receptor alpha signaling regulates monocyte homeostasis.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
10 2022
Historique:
revised: 18 08 2022
received: 29 10 2021
accepted: 23 08 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 9 9 2022
Statut: ppublish

Résumé

Interleukin-4 (IL-4) and its receptors (IL-4R) promote the proliferation and polarization of macrophages. However, it is unknown if IL-4R also influences monocyte homeostasis and if steady state IL-4 levels are sufficient to affect monocytes. Employing full IL-4 receptor alpha knockout mice (IL-4Rα

Identifiants

pubmed: 36063138
doi: 10.1096/fj.202101672RR
pmc: PMC9544925
doi:

Substances chimiques

Il4 protein, mouse 0
Il4ra protein, mouse 0
Receptors, Cell Surface 0
Interleukin-4 207137-56-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e22532

Informations de copyright

© 2022 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Références

Biochem Pharmacol. 2021 Aug;190:114634
pubmed: 34058186
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Haematologica. 2021 Feb 01;106(2):454-463
pubmed: 31974204
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cytometry A. 2011 Jun;79(6):461-9
pubmed: 21520400
Nat Immunol. 2013 Aug;14(8):821-30
pubmed: 23812096
Sci Immunol. 2019 Mar 1;4(33):
pubmed: 30824527
J Exp Med. 2013 Oct 21;210(11):2477-91
pubmed: 24101381
Sci Signal. 2008 Dec 23;1(51):ra17
pubmed: 19109239
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18055-60
pubmed: 22006336
Immunity. 2017 Dec 19;47(6):1024-1036
pubmed: 29262347
Nat Rev Mol Cell Biol. 2008 Mar;9(3):231-41
pubmed: 18073771
J Immunol. 1998 Nov 15;161(10):5507-15
pubmed: 9820527
Nat Immunol. 2008 Jan;9(1):25-33
pubmed: 18066066
JCI Insight. 2020 Feb 27;5(4):
pubmed: 32102987
FASEB J. 2022 Oct;36(10):e22532
pubmed: 36063138
Blood. 2010 Dec 9;116(24):5377-82
pubmed: 20829374
Eur J Cancer. 1993;29A(12):1700-7
pubmed: 8398297
J Biol Chem. 2014 Jan 10;289(2):838-47
pubmed: 24280217
Immunity. 2004 May;20(5):623-35
pubmed: 15142530
Immunity. 2018 Jun 19;48(6):1104-1117
pubmed: 29924976
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Blood. 2010 Oct 28;116(17):3311-20
pubmed: 20625006
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2265-2278
pubmed: 32673525
J Exp Med. 2016 Oct 17;213(11):2293-2314
pubmed: 27811056
Cell Death Dis. 2018 Jun 18;9(7):713
pubmed: 29915306
Sci Immunol. 2020 Feb 14;5(44):
pubmed: 32060143
FASEB J. 2008 Mar;22(3):659-61
pubmed: 17942826
JCI Insight. 2016 Jun 2;1(8):e86914
pubmed: 27699269
Immunity. 2010 May 28;32(5):593-604
pubmed: 20510870
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):792-801
pubmed: 9438489
Clin Exp Immunol. 2014 Jul;177(1):253-60
pubmed: 24580121
J Immunol. 1999 Jun 15;162(12):7302-8
pubmed: 10358179
Science. 2009 Jul 31;325(5940):612-6
pubmed: 19644120
J Immunol. 1989 Mar 15;142(6):1956-62
pubmed: 2921521
Blood. 2019 Aug 8;134(6):561-567
pubmed: 31221672

Auteurs

Patrick Haider (P)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Julia B Kral-Pointner (JB)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Manuel Salzmann (M)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Florian Moik (F)

Division of Haematology and Haemostaseology, Comprehensive Cancer Center, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Sonja Bleichert (S)

Division of Vascular Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.

Waltraud C Schrottmaier (WC)

Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria.

Christoph Kaun (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Mira Brekalo (M)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Michael B Fischer (MB)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Department of Biomedical Research, Danube University Krems, Krems, Austria.

Walter S Speidl (WS)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Christian Hengstenberg (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Bruno K Podesser (BK)

Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.

Kurt Huber (K)

3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria.
Medical Faculty, Sigmund Freud University, Vienna, Austria.

Ingrid Pabinger (I)

Division of Haematology and Haemostaseology, Comprehensive Cancer Center, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Sylvia Knapp (S)

Laboratory of Infection Biology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Frank Brombacher (F)

Institute of Infectious Disease and Molecular Medicine, International Center for Genetic and Biotechnology Cape Town Component & University of Cape Town, Cape Town, South Africa.

Christine Brostjan (C)

Division of Vascular Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.

Cihan Ay (C)

Division of Haematology and Haemostaseology, Comprehensive Cancer Center, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Johann Wojta (J)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
Core Facilities, Medical University of Vienna, Vienna, Austria.

Philipp J Hohensinner (PJ)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH